Long-Term Treatment With Deutetrabenazine Is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From an Open-Label Extension Study

被引：0
|
作者：
Hauser, Robert [1 ]
Barkay, Hadas [2 ]
Fernandez, Hubert [3 ]
Factor, Stewart [4 ]
Jimenez-Shahed, Joohi [5 ]
Gross, Nicholas [6 ]
Savola, Juha-Matti [7 ]
Anderson, Karen E. [8 ]
机构：
[1] Univ S Florida, Parkinsons Dis & Movement Disorders Ctr, Tampa, FL USA
[2] Teva Pharmaceut, Netanya, Israel
[3] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA
[4] Emory Univ, Atlanta, GA 30322 USA
[5] Baylor Coll Med, Houston, TX 77030 USA
[6] Teva Pharmaceut, Frazer, PA USA
[7] Teva Pharmaceut Int, Basel, Switzerland
[8] Georgetown Univ, Washington, DC USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S4.009
引用
收藏
页数：4
相关论文
共 50 条
  • [31] LONG-TERM SPARSENTAN TREATMENT IN FSGS IN THE DUET OPEN-LABEL EXTENSION (OLE)
    Trachtman, Howard
    Srivastava, Tarak
    Tesar, Vladimir
    Campbell, Kirk N.
    Rheault, Michelle N.
    Komers, Radko
    Murphy, Edward
    Prasad, Andy
    Gesualdo, Loreto
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S99 - S99
  • [32] LONG-TERM TREATMENT OF PARTIAL EPILEPSY WITH ESLICARBAZEPINE ACETATE: RESULTS OF A 1-YEAR OPEN-LABEL EXTENSION STUDY
    Guekht, A.
    Elger, C.
    Halasz, P.
    Maia, J.
    Almeida, L.
    Soares-da-Silva, P.
    [J]. EPILEPSIA, 2009, 50 : 106 - 106
  • [33] Long-Term Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines: Results From a 36-Month, Multicenter, Open-Label Extension Study
    Schlessinger, Joel
    Dover, Jeffrey S.
    Joseph, John
    Monheit, Gary
    Nelson, Diane B.
    Albright, Craig D.
    Axford-Gatley, Robert A.
    Cohen, Joel L.
    [J]. DERMATOLOGIC SURGERY, 2014, 40 (02) : 176 - 183
  • [34] Rapid Responders to Frovatriptan in Acute Migraine Treatment: Results from a Long-Term, Open-Label Study
    Spierings, Egilius L. H.
    Keywood, Charlotte
    [J]. PAIN MEDICINE, 2009, 10 (04) : 633 - 638
  • [35] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Pikalov, Andrei
    Correll, Christoph
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Loebel, Antony
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S178 - S178
  • [36] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Pikalov, A.
    Loebel, A.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29
  • [37] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [38] LONG-TERM PERAMPANEL USE IN OPEN-LABEL EXTENSION STUDIES
    Rektor, Ivan
    Krauss, Gregory L.
    Inoue, Yushi
    Kaneko, Sunao
    Williams, Betsy
    Patten, Anna
    Bibbiani, Francesco
    Laurenza, Antonio
    Wechsler, Robert T.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A23 - A23
  • [39] Safety of long-term use of linezolid: results of an open-label study
    Vazquez, Jose A.
    Arnold, Anthony C.
    Swanson, Robert N.
    Biswas, Pinaki
    Bassetti, Matteo
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1347 - 1354
  • [40] Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: Final results of an open-label, long-term extension study
    Vockley, Jerry
    Burton, Barbara K. K.
    Berry, Gerard
    Longo, Nicola
    Phillips, John
    Sanchez-Valle, Amarilis
    Chapman, Kimberly A. A.
    Tanpaiboon, Pranoot
    Grunewald, Stephanie
    Murphy, Elaine
    Lu, Xiaoxiao
    Rahman, Syeda
    Ray, Kathryn
    Reineking, Bridget
    Pisani, Laura
    Ramirez, Antonio Nino
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2023, 46 (05) : 943 - 955
12345